| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |